Accelerate Diagnostics Inc - Company Profile
Powered by
All the data and insights you need on Accelerate Diagnostics Inc in one report.
- Save hours of research time and resources with
our up-to-date Accelerate Diagnostics Inc Strategy Report
- Understand Accelerate Diagnostics Inc position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Accelerate Diagnostics Inc (Accelerate) is an in vitro diagnostics company engaged in the development and commercialization of instruments for the identification and testing of antibiotic susceptibility of infectious pathogens. Its product portfolio includes Accelerate Pheno system, a platform for the identification (ID) and antibiotic susceptibility testing (AST) of infectious pathogens; and Accelerate PhenoTest BC kit, which provides ID and AST results for patients with bacteremia or fungemia. It operates a manufacturing facility in Tucson, Arizona. The company sells products directly and also through a network of third-party distributors to hospital microbiology laboratories in domestic and foreign countries. Accelerate is headquartered in Tucson, Arizona, the US.
Accelerate Diagnostics Inc premium industry data and analytics
Products and Services
Products | Brands |
---|---|
Accelerate Pheno system | Accelerate Arc |
Accelerate PhenoTest BC Kit | Accelerate Pheno |
Sophonix MS-Fast | Accelerate PhenoTest |
XYZ | XYZ |
XYZ | XYZ |
XYZ | XYZ |
Competitor Comparison
Key Parameters | Accelerate Diagnostics Inc | Danaher Corp | Becton Dickinson and Co | bioMerieux SA | Bruker Corp |
---|---|---|---|---|---|
Headquarters | United States of America | United States of America | United States of America | France | United States of America |
City | Denver | Washington | Franklin Lakes | Craponne | Billerica |
State/Province | Colorado | WashingtonD.C. | New Jersey | Rhone Alpes | Massachusetts |
No. of Employees | 179 | 61,000 | 73,000 | 13,842 | 9,707 |
Entity Type | Public | Public | Public | Public | Public |
Key Financial Charts
Sales Growth
Net Income Growth
Executives
Name | Position | Board | Since | Age |
---|---|---|---|---|
Hany Massarany | Chairman | Executive Board | 2023 | 61 |
Jack Phillips | President; Chief Executive Officer; Director | Executive Board | 2020 | 58 |
David Patience | Chief Financial Officer | Senior Management | 2023 | 37 |
John Meduri | Chief Strategy Officer | Senior Management | 2020 | - |
Lawrence Mertz | Chief Technology Officer | Senior Management | 2022 | 61 |
Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer